The earliest optimal timing for total-body 68Ga-fibroblast activation protein inhibitor-04 PET scans: an evidence-based single-centre study

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

Haojun Chen, Yizhen Pang, Jingxun Wu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 540 citations

Medicine, Oncology, Radiology +12

Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers

Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 153 citations

Medicine, Nuclear Medicine, Radiology +12

Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT

Liang Zhao, Yizhen Pang, Zuoming Luo et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 148 citations

Medicine, Nuclear Medicine, Oncology +12

Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer

Hui Tan, Xiuli Sui, Hongyan Yin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 140 citations

Medicine, Nuclear Medicine, Radiology +14

[18F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [68Ga]Ga-FAPI-04

Kongzhen Hu, Lijuan Wang, Hubing Wu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 123 citations

Medicine, Nuclear Medicine, Radiology +14